Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Anaerobe. 2018 May 31;53:74–81. doi: 10.1016/j.anaerobe.2018.05.017

Table 1.

Comparison of mixed infection and dominant ribotype across 1) all samples collected and 2) index samples (primary C. difficile infection) in patients who did not recur (nonrecurrent), patients who recurred (subsequent CDI episode in 15–56 days), and patients who were reinfected (subsequent CDI episode > 8 weeks).

Across all samples Nonrecurrent Patients Recurrent Patients Reinfected Patients All Patients P
# Patients (% of Total Patients) 20 (32.8) 28 (45.9) 13 (21.3) 61 -
Age, mean (±SD) 58.3 (±20.3) 56.4 (±17.4) 58.6 (±15.7) 55.2 (±18.7) .89
Female gender, n (%) 10 (50) 18 (64.2) 6 (46.1) 34 (55.7) .5
PPI use, n (%) 7 (35) 5 (17.9) 3 (25) 15 (24.6) .4
Prior antibiotic use 7 (35) 6 (21.4) 2 (15.4) 15 (24.6) .4
Concurrent antibiotics, n (%) 16 (80) 15 (53.6) 7 (53.8) 38 (62) .1
Mean # samples per patient [IQR] 1.3 [1,1.25] 2.11 [1,3] 1.54 [1,2] 1.72 [1,2] .00023
Mean # colonies isolated 33.6 [26.3, 40] 35.1 [25, 44] 29.1 [13.5, 40] 33.6 [21, 43] .48
# samples with mixed infection (% samples in group) 12/26 (46.2) 42/59 (71) 8/20 (40) 62/105 (59) .015
Mean # of unique ribotypes in samples with mixed infection [IQR] 2.67 [2,3] 2.71 [2,3] 2.25 [2,2] 2.65 [2,3] .49
Most common dominant ribotype F014-020 F027 F078-126 F014-020 .38

At Index Sampling (1st documented CDI episode) Nonrecurrent Patients Recurrent Patients Reinfected Patients All Patients

# Index samples available (% samples in group) 19 (18.1) 14 (13.3) 3 (2.9%) 36 (34.3) -
# Index samples with mixed infection (% index samples in group) 7/19 (36.8) 11/14 (78.6) 1/3 (33.3) 19/36 (52.8) .047
Mean # of ribotypes in index samples with mixed infection [IQR] 3 [2,3] 2.38 [2,3] 2 [2,2] 2.57 [2,3] .59
Most common dominant ribotype (index) F002 F027 F019 F027 -

P values: Chi-squared test for categorical variables; ANOVA for continuous variables